Allarity Therapeutics, Inc. (ALLR)
NASDAQ: ALLR · Real-Time Price · USD
1.240
0.00 (0.00%)
At close: Mar 9, 2026, 4:00 PM EDT
1.280
+0.040 (3.23%)
After-hours: Mar 9, 2026, 7:59 PM EDT
Allarity Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 20 | 5 | 3 | 4 | 78 | - | |
| Market Cap Growth | 378.47% | 106.50% | -40.12% | -94.65% | - | - | |
| Enterprise Value | 5 | -12 | 4 | 3 | 73 | - | |
| Last Close Price | 1.24 | 1.17 | 330.66 | 246787.06 | 8714405.71 | - | |
| PB Ratio | 1.66 | 0.44 | -0.91 | 2.22 | 4.18 | - | |
| P/TBV Ratio | 1.67 | 0.44 | - | - | - | - | |
| Debt / Equity Ratio | 0.12 | 0.11 | -0.47 | 1.98 | 0.06 | 0.11 | |
| Net Debt / Equity Ratio | -1.29 | -1.55 | -0.39 | 0.88 | -1.00 | 0.09 | |
| Net Debt / EBITDA Ratio | 0.91 | 1.04 | -0.06 | -0.10 | 0.71 | -0.28 | |
| Net Debt / FCF Ratio | 1.03 | 1.03 | -0.08 | -0.10 | 1.27 | -0.32 | |
| Quick Ratio | 2.11 | 2.01 | 0.08 | 0.26 | 1.03 | 0.27 | |
| Current Ratio | 2.33 | 2.06 | 0.14 | 0.44 | 1.03 | 0.31 | |
| Return on Equity (ROE) | -122.61% | -541.17% | - | -155.34% | -123.30% | -27.76% | |
| Return on Assets (ROA) | -51.62% | -63.52% | -81.08% | -32.90% | -39.98% | -16.46% | |
| Return on Capital Employed (ROCE) | -141.60% | -148.50% | 743.10% | -508.50% | -91.80% | -29.80% | |
| Earnings Yield | -76.48% | -472.60% | -473.76% | -382.75% | -33.98% | - | |
| FCF Yield | -75.33% | -340.25% | -507.36% | -401.27% | -18.98% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.